Use of pimavanserin in patients with Parkinson's disease psychosis: subgroup analysis of efficacy and safety in patients with and without cognitive impairment

被引：0
|
作者：
Weintraub, D.
Norton, J.
Fredericks, D.
Coate, B.
Andersson, C.
Ballard, C.
机构：
来源：
MOVEMENT DISORDERS | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
137
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Use of pimavanserin in patients with Parkinson's disease psychosis: Subgroup analysis of efficacy and safety in patients with and without cognitive impairment
    Weintraub, D.
    Norton, J.
    Coate, B.
    Andersson, C.
    Fredericks, D.
    Ballard, C.
    MOVEMENT DISORDERS, 2017, 32 (09) : E15 - E15
  • [2] Clozapine: Efficacy for Parkinson Disease psychosis in patients refractory to pimavanserin
    Thames, Beatriz H.
    Ondo, William G.
    PARKINSONISM & RELATED DISORDERS, 2023, 109
  • [3] Pimavanserin for psychosis in Parkinson's disease dementia: Subgroup analysis of the HARMONY Trial
    Weintraub, Daniel
    Espay, Alberto J.
    Sharma, Vibhash D.
    Tariot, Pierre N.
    Abler, Victor
    Pathak, Sanjeev
    Stankovic, Srdjan
    PARKINSONISM & RELATED DISORDERS, 2024, 119
  • [4] PIMAVANSERIN FOR PSYCHOSIS IN PARKINSON'S DISEASE DEMENTIA: SUBGROUP ANALYSIS OF THE HARMONY TRIAL
    Weintraub, D.
    Espay, A. J.
    Sharma, V. D.
    Tariot, P. N.
    Abler, V.
    Pathak, S.
    Stankovic, S.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [5] The safety, tolerability and efficacy of pimavanserin tartrate in the treatment of psychosis in Parkinson's disease
    Hermanowicz, Stefan
    Hermanowicz, Neal
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (06) : 625 - 633
  • [6] Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis
    Abler, Victor
    Brain, Cecilia
    Ballard, Clive
    Berrio, Ana
    Coate, Bruce
    Espay, Alberto. J. J.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [7] Characteristics of Parkinson's Disease in Patients with and without Cognitive Impairment
    Chandler, Julie M.
    Nair, Radhika
    Biglan, Kevin
    Ferries, Erin A.
    Munsie, Leanne M.
    Changamire, Tich
    Patel, Nick
    JOURNAL OF PARKINSONS DISEASE, 2021, 11 (03) : 1381 - 1392
  • [8] Can pimavanserin help patients with Parkinson disease psychosis?
    de la Cruz, Jennifer
    Canal, Clinton
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (01): : 44 - 45
  • [9] An Open-Label Extension Study To Determine the Safety of Pimavanserin in Patients with Parkinson's Disease and Psychosis
    Mills, Roger
    Johnson, Ann D.
    Williams, Hilde
    Bahr, Daun
    Revell, Stephen
    NEUROLOGY, 2009, 72 (11) : A319 - A319
  • [10] Evidence for the use of pimavanserin in the treatment of Parkinson's disease psychosis
    Sarva, Harini
    Henchcliffe, Claire
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2016, 9 (06) : 462 - 473
12345